Earlier this year we reached our 100 millionth online product order placed through our online ordering portal! This was a huge milestone for VisionWeb as a company, and we wouldn't have reached the 100 millionth order if it weren't for the help of all of the ECPs who use our online lab ordering solution every day to order their ophthalmic products!
If you haven't heard, Uprise, our cloud-based practice management and EHR solution, has received Meaningful Use Stage 2 Certifcation as a Complete EHR! As 2014 rolls around, many of you might be looking for a practice management and EHR system for Meaningful Use Stage 2. If you are, make sure that your EHR is certified for Stage 2, because all EHR vendors will have to be re-certified.
Check out our infographic that covers a quick recap and comparison of Stage 1 and Stage 2 and find out what Stage 2 entails.
We hear the term "Cloud Computing" thrown around a lot these days but do you know what it actually is? The increasing buzz but lack of knowledge about cloud computing prompted us to create our very own infographic to help you understand the concept of the cloud a little better. Cloud computing is becoming increasingly popular in the eyecare industry, especially with optician software.
A lot of businesses, ourselves included, are active on both of the social networking mega-sites: Facebook and Twitter. That means we spend a fair amount of time on both. But, should we be doing that? Managing both? When you think about business solutions, you typically chose one - the one that is the best suited for your needs or delivers the most value - right? So why not do that here, in the social networking realm? Which one is more valuable? We think it's hard question to answer. Even though both are social networking sites, they are really quite different from each other. We interact with different types of people, all equally important to us, on each different platform. So we're not ready to abandon one and focus solely on the other, but we are interested to see how this all evolves.